Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

NIH licensing opportunity: materials and methods for inhibiting Wip1

March 28, 2003

Resubmitted Plenaxis NDA accepted for review

March 28, 2003

Development of BresaGen's E21R takes new direction

March 28, 2003

AEterna signs Neovastat marketing agreement for Korea

March 28, 2003

Novel phthalazine-based protein kinase inhibitors in Pharmacia pipeline

March 28, 2003

New series of PDE10A inhibitors with utility in cancer identified at Bayer

March 28, 2003

Antitumor polyketides prepared and tested at Novartis

March 28, 2003

Novartis patents new antitumor tyrosine kinase inhibitors

March 28, 2003

Progress on three fronts in OGS/Medarex alliance

March 27, 2003

CPMP recommends approval of Busulfex in Europe

March 27, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...